HI
ANIP icon

Horizon Investments’s ANI Pharmaceuticals ANIP Stock Holding History

Horizon Investments’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$810K Buy
9,779
+360
+4% +$28.9K 0.01% 809
2026
Q1 		$724K Buy
+9,419
New +$735K 0.01% 763
2025
Q4 		– Sell
-5,960
Closed -$546K – 1306
2025
Q3 		$546K Buy
+5,960
New +$486K 0.01% 805

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Horizon Investments's ANIP Position: Q2 2026 in Review

Horizon Investments increased its ANI Pharmaceuticals (ANIP) stake by 3.8% in Q2 2026, buying an estimated $28.9K and bringing the position to 9,779 shares worth $810K. The position accounts for 0.01% of the portfolio, ranked #809.

Horizon Investments first reported a position in ANIP in Q3 2025 and has held it in 3 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Horizon Investments held 9,779 shares of ANI Pharmaceuticals worth $810K as of Q2 2026.
  • Horizon Investments bought 360 ANI Pharmaceuticals shares in Q2 2026, an estimated $28.9K.
  • ANI Pharmaceuticals made up 0.01% of Horizon Investments's portfolio in Q2 2026, its #809 holding.
  • Horizon Investments first reported a position in ANI Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.